(R) receives ‘s (Source: VNA)Hanoi (VNA) – US-based Pfizer Group, one of the world’s premier
biopharmaceutical companies, has signed an agreement on the transfer of
pharmaceutical production technology to Vietnamese enterprises, so first
products are scheduled to be produced in 2020.
The information was
made by the group’s Regional President for Asia and Emerging Markets Pierre
Gaudreault in a meeting with Vietnam’s National Assembly Vice Chairman Phung
Quoc Hien in Hanoi on January 10.
Pierre Gaudreault
affirmed that the signing of the deal shows Pfizer’s commitment to long-term
investment in Vietnam, thus contributing to the country’s pharmaceutical
industry and applying technology with international standard in its drug
production.
According to him, the
group decided to invest in Vietnam as it sees potential of the Vietnamese
market and its surrounding areas as well as the country’s open investment
policies.
He pledged to share
the group’s best experiences with Vietnamese enterprises, while hoping that the
Vietnamese Government will continue creating conditions on policies and
procedures for the group to expand its presence in the country.
NA Vice Chairman Phung
Quoc Hien stated that the transfer of technology is a breakthrough in the two
sides’ cooperation. This not only is a good chance for Vietnam’s pharmaceutical
producers to improve their capacity, but also helps Vietnamese people buy
high-quality drugs at reasonable prices.
He suggested Pfizer
study Vietnam’s climate to produce types of drugs that are suitable to
Vietnamese and Southeast Asian markets.
He affirmed that
Vietnam will facilitate investment of foreign enterprises, including
Pfizer.-VNA
Source: VietnamPlus
